EUVIMEDEUVIMED entdecken
Crossref

Chimeric hBPI23-Fcγ protein shows bactericidal activity against drug-resistant Gram-negative bacteria and protects mice from lethal challenge

Tianxiao Ma, Yang Wang, Chaoben Huang, Xulong Zhang, Yunqing An, Qi Zhang, Qingli Kong, Bin Cao

Archives of Microbiology · 2025

DOI: 10.1007/s00203-025-04306-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2025. Verfasst von Tianxiao Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antimicrobial Cationic Peptides, Blood Proteins, Recombinant Fusion Proteins. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, Medical Innovation Capacity Enhancement Special Program of Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antimicrobial peptides, such as host immune system-derived human bactericidal/permeability-increasing protein (hBPI), are the potential drugs for antibiotic-resistant Gram-negative bacterial infection. However, whether the purified chimeric hBPI23-Fcγ protein has bactericidal activity against drug-resistant Gram-negative bacteria (GNB) and the relevant mechanisms have not been fully elucidated. In this study, the chimeric hBPI23-Fcγ protein, which consisting of the functional N terminus of BPI and Fcγ1, were expressed and purified in a lab-scale. The chimeric hBPI23-Fcγ protein showed longer half-life up to 148.2 min in vivo. The hBPI23-Fcγ protein also showed significant bactericidal activity against standard and clinically isolated drug-resistant Acinetobacter baumannii (A. baumannii) and Escherichia coli (E. coli). In addition, the hBPI23-Fcγ protein markedly decreased biofilm formation, neutralized bacterial lipopolysaccharides (endotoxin) and enhanced the opsonization of phagocytes, as well as significantly improved the survival rate of minimal lethal dose (MLD) of drug-resistant E. coli -infected mice. These results indicate that the BPI23-Fcγ protein protected mice from drug-resistant GNB infection not only by direct bactericidal effect, but also by promoting opsonophagocytosis of macrophages. In conclusion, the chimeric BPI23-Fcγ protein may be as a promising candidate of non-antibiotic biological agent for drug-resistant GNB infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesBlood ProteinsRecombinant Fusion ProteinsGram-Negative BacteriaGram-Negative Bacterial InfectionsAnimalsMiceAcinetobacter baumanniiEscherichia coliMicrobial Sensitivity TestsBiofilmsHumansPore Forming Cytotoxic ProteinsDrug Resistance, BacterialFemaleMice, Inbred BALB CAcinetobacter Infections

Stichwörter der Autor:innen

Antimicrobial peptidesBactericidal/permeability-increasing protein (BPI)Drug-resistant gram-negative bacteriaOpsonization

Substanzen

Anti-Bacterial AgentsAntimicrobial Cationic Peptidesbactericidal permeability increasing proteinBlood ProteinsPore Forming Cytotoxic ProteinsRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, China.
  • Beijing Anjun Genetech Co., LTD., Beijing, China.
  • Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
  • Department of Respiratory Medicine, The First Hospital Affiliated to Army Medical University (Third Military Medical University), Chongqing, China.
  • Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. kongql@ccmu.edu.cn.

Förderung

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • Medical Innovation Capacity Enhancement Special Program of Capital Medical University

Zitieren

APA

Ma, T., Wang, Y., Huang, C., Zhang, X., An, Y., Zhang, Q., Kong, Q., & Cao, B. (2025). Chimeric hBPI23-Fcγ protein shows bactericidal activity against drug-resistant Gram-negative bacteria and protects mice from lethal challenge. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04306-2

Vancouver

Ma T, Wang Y, Huang C, Zhang X, An Y, Zhang Q, et al. Chimeric hBPI23-Fcγ protein shows bactericidal activity against drug-resistant Gram-negative bacteria and protects mice from lethal challenge. Archives of Microbiology. 2025. doi:10.1007/s00203-025-04306-2

BibTeX
@article{Ma2025,
  author = {Ma, Tianxiao and Wang, Yang and Huang, Chaoben and Zhang, Xulong and An, Yunqing and Zhang, Qi and Kong, Qingli and Cao, Bin},
  title = {Chimeric hBPI23-Fcγ protein shows bactericidal activity against drug-resistant Gram-negative bacteria and protects mice from lethal challenge},
  journal = {Archives of Microbiology},
  year = {2025},
  doi = {10.1007/s00203-025-04306-2}
}
Kostenlos starten →